Trial intelligence / Profile preview

Pidrolax vs paraffin vs lactulose for chronic functional constipation in children

IRCT20211223053493N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Apr 2022
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in functional constipation (FC) comparing Pidrolax, Lactulose and Paraffin (3 arms). Primary endpoints: Number of defecations per week, Stool consistency and 4 more. Started Apr 2022; status: completed.

02

Drugs

macrogol 4000Paraffinlactulose
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on IRCT20211223053493N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211223053493N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call